European Patent Office
EirGen Pharma and Meissner Bolte defend basic patent for kidney drug
An important basic patent for EirGen Pharma's drug Rayaldee for the treatment of chronic kidney disease in adults remains valid. This was decided by the Boards of Appeal at the EPO. However, this does
...
3 March 2026 by Mathieu Klos